Bleeding Disorders
Conference Coverage
Early intensive prophylaxis provides better QoL in hemophilia
Key clinical point: Early initiation of intensive bleeding prophylaxis was associated with significantly better health-related quality of life (...
Conference Coverage
Decision rule identifies unprovoked VTE patients who can halt anticoagulation
ROME – Half of women who have a first unprovoked venous thromboembolism can safely be spared lifelong anticoagulation through application of the...
News
FDA grants drug orphan designation for PNH
The US Food and Drug Administration (FDA) has granted orphan drug designation to Coversin as a treatment for paroxysmal nocturnal hemoglobinuria (...
News
Saline comparable to drug therapy for epistaxis in HHT
Photo courtesy of the University of Utah Health Sciences Center Results of a phase 2 study suggest a saline nose spray may be as effective as 3...
News
Bevacizumab no better than placebo for epistaxis in HHT
of nasal spray Bevacizumab nasal spray is no more effective than a placebo for reducing epistaxis caused by hereditary hemorrhagic telangiectasia...
News
ASH launches sickle cell coalition
The coalition aims to develop evidence-based treatment guidelines, educate clinicians, invest in research and clinical trials, and expand early...
Conference Coverage
Andexanet controlled factor Xa inhibitor–related bleeding
Key clinical point: Andexanet alfa achieved effective hemostasis in most patients with acute major bleeding on factor Xa inhibitors. Major finding...
Conference Coverage
Hemophilia carriers are at risk for abnormal bleeding
Conference Coverage
No VTE prophylaxis needed after joint surgery in patients with hemophilia
Key clinical point: Prophylaxis against thromboembolic events after orthopedic surgery in patients with hemophilia may not be necessary. Major...
Conference Coverage
Hematuria a common finding in pediatric hemophilia
Key clinical point:. Hematuria is a common finding in children with hemophilia A or B. Major finding: Of 93 patients with hemophilia, 43 (47%) had...
Conference Coverage
Hemophilia may not be protective against CVD
Key clinical point: Hemophilia has traditionally been considered protective against CVD but data presented at the World Federation of Hemophilia...